Announce Date | 04/29/2025 |
EPS Normalized Actual | $8.22 (Miss by $-0.4) |
EPS GAAP Actual | $8.22 (Miss by $-0.4) |
Revenue Actual | $3.0287B |
Revenue Surprise | Beat by $3028.7M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $14.07 |
EPS GAAP Estimate | $14.07 |
Revenue Estimate | $3.893391B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 67.57 | 7.81 | 61.68301 | 75.0396 | 5 |
Dec 2028 | 62.6903 | 8.41 | 57.33654 | 69.04652 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 7.58 | -6.22 | 3.0287B | -3.84% | -747.22M |
FQ4 2024 (Dec 2024) | 8.53 | -3.33303 | 3.7892B | 9.37% | 228.86M |
FQ3 2024 (Sep 2024) | 12.4 | 12.4 | 3.7207B | 9.62% | 3720.7M |
FQ2 2024 (Jun 2024) | 13.25 | 13.25 | 3.5471B | 10.97% | 3547.1M |
FQ1 2024 (Mar 2024) | 6.7 | 6.7 | 3.145B | -0.54% | 3145M |
FQ4 2023 (Dec 2023) | 10.88 | 10.88 | 3.4343B | 0.58% | 3434.3M |
FQ3 2023 (Sep 2023) | 9.48 | 9.48 | 3.3627B | 12.68% | 3362.7M |
FQ2 2023 (Jun 2023) | 9.05 | 9.05 | 3.1581B | 9.53% | 3158.1M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
14.07
Consensus Revenue Estimates
3.893391B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 12.56 | -- | 11.61544 | 13.6517 | 13 |
FQ2 2027 (Jun 2027) | 11.36 | -- | 10.50568 | 12.34739 | 8 |
FQ1 2027 (Mar 2027) | 9.37 | -- | 8.66534 | 10.18443 | 8 |
FQ4 2026 (Dec 2026) | 12.93 | -- | 11.80451 | 14.32451 | 3 |
FQ3 2026 (Sep 2026) | 12.55 | -- | 11.45758 | 13.90353 | 3 |
FQ2 2026 (Jun 2026) | 10.03 | -- | 9.15694 | 11.11175 | 3 |
FQ1 2026 (Mar 2026) | 9.65 | 21.45 | 8.81002 | 10.69076 | 3 |
FQ4 2025 (Oct 2025) | 12.2625 | 30.44 | 11.12777 | 13.16706 | 8 |
FQ3 2025 (Jul 2025) | 11.555 | -7.31 | 10.48574 | 12.40737 | 8 |
FQ2 2025 (Jun 2025) | 14.07 | 5.83 | 12.8086 | 15.41546 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.72B | -- | 3.51B | 3.97B | 14 |
FQ2 2027 (Jun 2027) | 3.62B | -- | 3.41B | 3.86B | 9 |
FQ1 2027 (Mar 2027) | 3.33B | -- | 3.14B | 3.55B | 9 |
FQ4 2026 (Dec 2026) | 4.14B | -- | 3.86B | 4.48B | 4 |
FQ3 2026 (Sep 2026) | 3.99B | -- | 3.73B | 4.32B | 4 |
FQ2 2026 (Jun 2026) | 3.67B | -- | 3.42B | 3.97B | 4 |
FQ1 2026 (Mar 2026) | 3.55B | 14.61 | 3.31B | 3.84B | 4 |
FQ4 2025 (Oct 2025) | 3.76B | -0.78 | 3.49B | 3.97B | 6 |
FQ3 2025 (Jul 2025) | 3.62B | -2.91 | 3.36B | 3.82B | 7 |
FQ2 2025 (Jun 2025) | 3.89B | 8.89 | 3.62B | 4.18B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 13.8 | 7.58 | -6.22 | -82.06% |
FQ4 2024 (Dec 2024) | 11.86303 | 8.53 | -3.33303 | -39.07% |
FQ3 2024 (Sep 2024) | 12.4 | 12.4 | 100% | |
FQ2 2024 (Jun 2024) | 13.25 | 13.25 | 100% | |
FQ1 2024 (Mar 2024) | 6.7 | 6.7 | 100% | |
FQ4 2023 (Dec 2023) | 10.88 | 10.88 | 100% | |
FQ3 2023 (Sep 2023) | 9.48 | 9.48 | 100% | |
FQ2 2023 (Jun 2023) | 9.05 | 9.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $3.78B | $3.03B | $-747.22M | -24.67% |
FQ4 2024 (Dec 2024) | $3.56B | $3.79B | $228.86M | 6.04% |
FQ3 2024 (Sep 2024) | $0B | $3.72B | $3720.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.55B | $3547.1M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.15B | $3145M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.43B | $3434.3M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.36B | $3362.7M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.16B | $3158.1M | 100% |